Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

200 studies match

clinicaltrialsPublishedShowing 51–100 of 200 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03041311	Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC	completed	Phase 2	107	G1 Therapeutics, Inc.INDUSTRY	7	Sep 25, 2025	clinicaltrials
NCT00532155	A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer(VITAL)	completed	Phase 3	913	SanofiINDUSTRY	32	Sep 10, 2025